1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
NIH Director's Awards (DP1, DP2) is sponsored by National Library of Medicine - NIH. Supports scientists with outstanding records of creativity pursuing new research directions to develop pioneering approaches to major challenges in the NLM Scientific Areas of Interest. These awards are part of the NIH High-Risk, High-Reward Research Program.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the opportunity page linked on this listing to help you evaluate fit faster.
NIH Director's New Innovator Award | NIH Common Fund NIH Director's New Innovator Award NIH Director's New Innovator Award FY2026 NIH Director’s New Innovator Award informational video Part of the High-Risk, High-Reward Research program, the NIH Director's New Innovator Award supports early career investigators of exceptional creativity who propose bold and highly innovative research projects with the potential to produce a major impact on broad, important areas relevant to the NIH mission.
Part of the High-Risk, High-Reward Research program , the award supports early career investigators of exceptional creativity who propose bold and highly innovative research projects with the potential to produce a major impact on broad, important areas relevant to the NIH mission.
Must have Early Stage Investigator status (completed doctoral degree or postgraduate clinical training within last 10 years and never received a substantial NIH independent research award) No preliminary data required Minimum of 25% research effort $475,000/year for 5 years See the Award Overview for more information. Applications due August 17, 2026.
Application & Award Guide Recent News & Announcements Harnessing Immune Cells to Deliver Brain Implants Without Surgery How Cellular Receptors Could Be Targeted to Treat Disease Nanoparticle Breakthrough Shows Potential for Treating Pre-Eclampsia Technological Improvements Propel Kidney Disease Research Forward This page last reviewed on
According to the current listing, eligibility includes: Scientists with outstanding records of creativity pursuing new research directions to develop pioneering approaches to major challenges in NLM Scientific Areas of Interest. Confirm the full requirements in the official notice before applying.
NIH Director's Awards (DP1, DP2) is funded by National Library of Medicine - NIH. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
PAR-26-042 funds NLM-priority clinical informatics R01 grants up to $250,000 in direct costs per year through March 6, 2029, with standard NIH cycles on October 5, February 5, and June 5. The notice explicitly defines non-responsive applications: incremental tool improvements, projects primarily focused on social determinants of health, and projects primarily focused on ethical/legal/social issues. With NIH SBIR/STTR just reopened and the OMB Uniform Grants Regulation rewrite reshaping discretionary awards, the NLM clinical informatics line is one of the few stable, well-defined biomedical funding streams left at the agency. Here is how to read it.
Read articleThe NIH Common Fund launched PRIMED-AI — Precision Medicine with AI: Integrating Imaging with Multimodal Data — as five coordinated funding opportunities (RFA-RM-27-011 through -015) that build a full pipeline from standards to clinic. Here is how the Playbook, Data-to-Model partnerships, Model-to-Clinic translation, Validation Center, and Logistics Center fit together, what each pays, who is eligible, and how to position before the October 2026 deadlines.
Read articleThe All of Us X01 is a Resource Access Award, not a funding award. It conveys serum, plasma and genomic DNA from a 613,000-participant biobank, requires you to prove you already have the money, and gives you nine months of exclusivity before your own assay data goes public.
Read article